Anti-VAMP2 antibody (STJ13102601)
SPECIFICATIONS
ClonalityPolyclonal
HostSheep
ConjugationUnconjugated
IsotypeIgG
ImmunogenA synthetic peptide from human VAMP2 conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in many other species including rat, mouse and xenopus.
General Information
| Short Description | Sheep polyclonal anti-VAMP2 for use in IHC and WB in Human, Rat and Mouse samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC/WB |
| Host | Sheep |
| Reactivity | Human/Rat/Mouse |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Purification | IgG purified |
| Dilution Range | IHC, WB. A concentration of 10-50 ยตg/ml is recommended. The optimal concentration should be determined by the end user. Not yet tested in other applications. |
| Formulation | Lyophilised |
| Storage Instruction | Maintain the lyophilised/reconstituted antibodies frozen at-20ยฐC for long term storage and refrigerated at 2-8ยฐC for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
Target Information
| Gene Symbol | VAMP2 |
| Gene ID | 6844 |
| Uniprot ID | VAMP2_HUMAN |
| Immunogen | A synthetic peptide from human VAMP2 conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in many other species including rat, mouse and xenopus. |
| Specificity | Specific for VAMP2. |
Additional Info
| Post Translational Modifications | Phosphorylated by PRKCZ in vitro and this phosphorylation is increased in the presence of WDFY2. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type B (BoNT/B, botB) which hydrolyzes the 76-Gln-|-Phe-77 bond and probably inhibits neurotransmitter release. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type D (BoNT/D, botD) which probably hydrolyzes the 59-Lys-|-Leu-60 bond and inhibits neurotransmitter release. Note that humans are not known to be infected by C.botulinum type D. (Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type F (BoNT/F, botF) which hydrolyzes the 58-Gln-|-Lys-59 bond and probably inhibits neurotransmitter release. (Microbial infection) Targeted and hydrolyzed by C.tetani tetanus toxin (tetX) which hydrolyzes the 76-Gln-|-Phe-77 bond and probably inhibits neurotransmitter release. |
| Function | Involved in the targeting and/or fusion of transport vesicles to their target membrane. Major SNARE protein of synaptic vesicles which mediates fusion of synaptic vesicles to release neurotransmitters. Essential for fast vesicular exocytosis and activity-dependent neurotransmitter release as well as fast endocytosis that mediates rapid reuse of synaptic vesicles. Modulates the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1. |
| Protein Name | Vesicle-Associated Membrane Protein 2Vamp-2Synaptobrevin-2 |
| Database Links | Reactome: R-HSA-1445148Reactome: R-HSA-181429Reactome: R-HSA-181430Reactome: R-HSA-199992Reactome: R-HSA-210500Reactome: R-HSA-212676Reactome: R-HSA-264642Reactome: R-HSA-264876Reactome: R-HSA-422356Reactome: R-HSA-432720Reactome: R-HSA-432722Reactome: R-HSA-449836Reactome: R-HSA-5250955Reactome: R-HSA-5250958Reactome: R-HSA-5250981Reactome: R-HSA-5250982Reactome: R-HSA-5250989Reactome: R-HSA-8856825Reactome: R-HSA-8856828Reactome: R-HSA-888590Reactome: R-HSA-9609523Reactome: R-HSA-9662360 |
| Cellular Localisation | Cytoplasmic VesicleSecretory VesicleSynaptic Vesicle MembraneSingle-Pass Type Iv Membrane ProteinCell MembraneColocalizes With Prkcz And Wdfy2 In Intracellular Vesicles |
| Alternative Antibody Names | Anti-Vesicle-Associated Membrane Protein 2 antibodyAnti-Vamp-2 antibodyAnti-Synaptobrevin-2 antibodyAnti-VAMP2 antibodyAnti-SYB2 antibody |
Information sourced from Uniprot.org